Author:
Kazmi Imran,Afzal Muhammad,Al-Abbasi Fahad A.,AlGhamdi Shareefa A.,Alghamdi Amira M.,Alzarea Sami I.,Almalki Waleed Hassan,AlGhamdi Abeer S.,Alkinani Khadijah B.,Sayyed Nadeem
Funder
Deanship of Scientific Research at Umm Al-Qura University
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,General Medicine
Reference60 articles.
1. Alexander J, Barregård L, Bignami M, Brüschweiler B, Ceccatelli S, Dinovi M, Edler L, Grasl-Kraupp B, Hogstrand C, Hoogenboom L (2016) Erucic acid in feed and food. EFSA J. 14(11):4593
2. Altinoz MA, Ozpinar A (2019) Ppar-δ and erucic acid in multiple sclerosis and Alzheimer’s disease. Likely benefits in terms of immunity and metabolism. Int immunopharmacol 69:245–256
3. Altinoz MA, Bilir A, Elmaci İ (2018) Erucic acid, a component of Lorenzo’s oil and ppar-δ ligand modifies c6 glioma growth and toxicity of doxorubicin. Experimental data and a comprehensive literature analysis. Chem Biol Interact 294:107–117
4. Altinoz MA, Ozpinar A, Ozpinar A, Hacker E (2020) Erucic acid, a nutritional pparδ-ligand may influence Huntington’s disease pathogenesis. Metab Brain Dis 35(1):1–9
5. Altinoz MA, Elmaci İ, Hacimuftuoglu A, Ozpinar A, Hacker E, Ozpinar A (2021) Pparδ and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson’s disease. Mol Aspects Med 78:100871